This Week in Nephrology — Sep 30, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Nephrology. This week we're covering 10 notable papers spanning frailty and physical function in kidney disease, cardiovascular-kidney-metabolic pharmacotherapy, immune-mediated glomerular disease, and a pair of studies on transplant infec… This week's papers: Recommendations for the management of frailty in chronic kidney disease: a consensus report. — Nature Reviews Nephrology 2026 Physical Performance and Risk of Heart Failure, Kidney Failure, and Mortality in CKD: Findings from the CRIC Study. — Clinical Journal of the American Society of Nephrology 2026 Efficacy and Safety of Incremental Hemodialysis: A Systematic Review and Meta-Analysis. — Seminars in Dialysis 2026 Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2 Diabetes and CKD. — Clinical Journal of the American Society of Nephrology 2026 Targeting the aldosterone-mineralocorticoid receptor pathway in cardiovascular-kidney-metabolic syndrome. — Nature Reviews Nephrology 2026 Prospective 96-week study to evaluate efficacy and safety of tacrolimus and glucocorticoid against mycophenolate and glucocorticoid as continuous induction-maintenance treatment for Class III/IV without or with Class V lupus nephritis. — Kidney International 2026 Unmet Needs in the Management of Adult Patients with Lupus Nephritis. — Nephrology Dialysis Transplantation 2026 Long-term outcomes of childhood nephrotic syndrome. — Kidney International 2026 Early BK Polyomavirus-Specific Immunity and Viral Clearance. — Kidney International Reports 2026 Data from the French Daily-Luma cohort suggest predictors of a lumasiran response. — Kidney International 2026 Listen at AudioScholar